Cooley and Wilson Sonsini Goodrich & Rosati advised Vividion Therapeutics on the deal. Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Iterative Scopes on the deal. Iterative Scopes, a pioneering company aiming to bring cutting-edge precision medicine to gastroenterology, closed a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tybourne Capital Management on the deal. Zentera Therapeutics, a clinical-stage biopharmaceutical company, completed a $75 million Series B financing. Founding investors...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BigCommerce on the deal. BigCommerce, a leading Open SaaS ecommerce platform for fast-growing and established brands, announced it has acquired...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Epic on the deal while Cooley LLP represented Byju’s. The global leader in personalized online learning, BYJU’s (backed by General...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the IPO while Wilson Sonsini Goodrich & Rosati represented Couchbase. Couchbase, Inc. executed its initial public offering...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Totient on the deal. AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced the acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal. Arena Pharmaceuticals, Inc. and Aristea Therapeutics, Inc. announced a strategic collaboration to advance the clinical...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal. Aristea announced the closing of a $63 million Series B financing led by Fidelity Management &...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Inspire Energy Capital on the deal. Shell New Energies US LLC, a subsidiary of Royal Dutch Shell plc, announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Medallia on the deal. Latham & Watkins represented Blackstone Alternative Credit Advisors as the lead lender, as well as credit arms...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Carbon Health on the deal. Carbon Health announced that it raised $350 million. With the investment, Carbon Health, a leading...
You must be a Standard 1 Year member to access this content.
